Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18LANTHEUS MEDCL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 9789210

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-03-16

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 10588988

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-05-04

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 10583208

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-03-16

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 10588988

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-05-04

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 9789210

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-03-16

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 10583207

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2035-12-28

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 10583207

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2035-12-28

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 10583208

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-03-16

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 11925695

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-03-16

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PERFLUTREN

US Patent Number : 11925695

Drug Substance Claim :

Drug Product Claim :

Application Number : 21064

Patent Use Code : U-665

Delist Requested :

Patent Use Description : METHOD OF USING THE DR...

Patent Expiration Date : 2037-03-16

blank